Targeting the 5' untranslated region of SMN2 as a therapeutic strategy for spinal muscular atrophy
Spinal muscular atrophy (SMA) is a neuromuscular disorder caused by mutations in the survival motor neuron 1 (<i>SMN2</i>) gene. All patients have at least one copy of a paralog, <i>SMN2</i>, but a C-to-T transition in this gene results in exon 7 skipping in a majority of tra...
Auteurs principaux: | Winkelsas, AM, Grunseich, C, Harmison, GG, Chwalenia, K, Rinaldi, C, Hammond, SM, Johnson, K, Bowerman, M, Arya, S, Talbot, K, Wood, MJ, Fischbeck, KH |
---|---|
Format: | Journal article |
Langue: | English |
Publié: |
Cell Press
2021
|
Documents similaires
-
Targeting the 5′ untranslated region of SMN2 as a therapeutic strategy for spinal muscular atrophy
par: Audrey M. Winkelsas, et autres
Publié: (2021-03-01) -
Targeting the 5' untranslated region of SMN2 as a therapeutic strategy for spinal muscular atrophy
par: Winkelsas, AM
Publié: (2020) -
Therapeutic strategies for spinal muscular atrophy: SMN and beyond
par: Bowerman, M, et autres
Publié: (2017) -
Therapeutic strategies for spinal muscular atrophy: SMN and beyond
par: Bowerman, M, et autres
Publié: (2017) -
Therapeutic strategies for spinal muscular atrophy: SMN and beyond
par: Melissa Bowerman, et autres
Publié: (2017-08-01)